Investors Jumping Ship When It Comes to ESCR?

From a recent Zenit report, we read encouraging news:

PHILADELPHIA, Pennsylvania, JULY 29, 2007 (Zenit.org).- A prominent bioethicist says he hopes that the closure of ES Cell International, a leading embryonic stem cell research facility, is a sign of growing realism.

Father Tadeusz Pacholczyk commented on the closure of the biotechnology firm in Singapore, telling ZENIT, "We can only hope that a certain realism may finally be sinking in, as Wall Street types recognize that the timeline for clinical therapies is likely to be quite long."

The firm closed when investors concluded that "the likelihood of having products in the clinic in the short term was vanishingly small," Alan Colman, former chief executive of ES Cell International, told Science magazine...

As more and more people begin to realize that their best option is to salvage what little investment they have left (if any) for such horrid scientific research, future funding from investors might be more difficult to obtain, which appears to be why many embryonic stem cell research firms are seeking goverment handouts and free, unlimited feedings at the public trough - yet another taxpayer-funded corporate welfare scheme designed to line the pockets of those engaged in evil and immoral practices.

Father Pacholczyk says, "...it is clear that some investors are exercising caution about stepping into the midst of what has certainly become an ethical minefield."

Let us hope and pray that this attitude, this reality, becomes more prevalent and that embryonic stem cell research is effectively (and legally) banned as the moral evil it truely is.